Clinical trial Recruiting at 1 site Interventional Ages 20 to 50 Women only

Effect of shockwave or electromagnetic therapy with pelvic floor training on female sexual dysfunction

Official title: Effects of Extracorporeal Shockwave Therapy Versus Pulsed Electromagnetic Field Therapy in Females With Sexual Dysfunction: a Randomized Controlled Trial

Run by Benha University · NCT07584174 · Data updated 2026-11-12

This trial tests whether adding shockwave therapy or pulsed electromagnetic field therapy to pelvic floor training helps women with sexual dysfunction.

More Pelvic Floor Muscle Training trials

Quick facts

Study typeInterventional
Ages20 Years to 50 Years
SexWomen only
Enrollment90 (estimated)
SponsorBenha University
Academic / other
Drugs / interventionsradiation
Locations1 site (Banī Suwayf)
StatusRecruiting
StartedMay 14, 2026
Main results expectedDecember 15, 2026
Study endsJanuary 15, 2027
Registry record updatedMay 18, 2026
Trial IDNCT07584174 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Premenopausal women aged 20-50 with FSD (FSFI < 26.55), in a stable sexual relationship, and willing to refrain from other treatments during the study.

Probably not a fit

Women without FSD symptoms, those outside the age range, or those who receive less benefit from pelvic floor training alone may not see improvement.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized study compares three approaches for female sexual dysfunction: shockwave therapy plus pelvic floor muscle training, pulsed electromagnetic field therapy plus pelvic floor training, and pelvic floor training alone. Ninety premenopausal women with FSFI scores below 26.55 are enrolled and randomly assigned to one of the three groups for 8 weeks of treatment with an 8-week follow-up. Assessors are blinded to treatment allocation to reduce bias. The goal is to determine which combination best improves sexual function and related symptoms. The study is conducted at Benha University with collaboration from Beni-Suef University and uses standard, supervised pelvic floor training across all arms.

Why it matters

Potential benefit: If successful, participants could experience improved sexual function and related symptoms through non-pharmacologic, non-invasive options.

How similar studies have gone: Previous research in related areas suggests potential benefits from energy-based therapies and pelvic floor training, but direct head-to-head data in this population are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Female participants aged 20-50 years diagnosed with female sexual dysfunction (FSFI score \<26.55), reporting symptoms of reduced sexual desire, arousal dysfunction, orgasmic dysfunction, or dyspareunia.
2. Premenopausal women in a stable sexual relationship for at least 6 months and sexually active during the previous month.
3. Symptoms persisting for at least 3 months before enrollment.
4. Ability to understand study procedures and provide written informed consent.
5. Willingness to refrain from initiating any additional treatment for sexual dysfunction during the study period

Exclusion Criteria:

1. Pregnancy or planned pregnancy during the study period.
2. Pelvic surgery within the previous 6 months.
3. Active pelvic inflammatory disease, genital infection, or unexplained vaginal bleeding.
4. Neurological disorders affecting pelvic floor or sexual function.
5. Severe pelvic organ prolapse, severe urinary incontinence, or significant pelvic anatomical abnormalities.
6. Current hormonal therapy or use of medications known to affect sexual function, including antidepressants or antipsychotics.
7. Severe psychiatric disorders or cognitive impairment limiting participation.
8. Menopause or perimenopausal status.
9. Uncontrolled systemic diseases such as diabetes mellitus, hypertension, cardiovascular disease, or thyroid disorders.
10. Presence of malignancy, pelvic radiation history, or severe chronic pelvic pain disorders.
11. Contraindications to ESWT or PEMF including cardiac pacemakers or implanted electronic devices, coagulation disorders, anticoagulant therapy, epilepsy, or metal implants in the pelvic region.
12. Current participation in another clinical trial or receipt of physiotherapy for sexual dysfunction within the previous 3 months.

Where it's running

  • Outpatient clinic, faculty of Physical Therapy, Beni Suef University
    Banī Suwayf, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.